Safety and Prophylactic Efficacy of Liposome-Based Vaccine against the Drug-Resistant <i>Acinetobacter baumannii</i> in Mice
In recent years, the emergence of multidrug-resistant <i>Acientobacter baumannii</i> has greatly threatened public health and depleted our currently available antibacterial armory. Due to limited therapeutic options, the development of an effective vaccine formulation becomes critical in...
Main Authors: | Masood Alam Khan, Khaled S. Allemailem, Hamzah Maswadeh, Hina Younus |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/7/1357 |
Similar Items
-
Glycosphingolipids (GSLs) from <i>Sphingomonas paucimobilis</i> Increase the Efficacy of Liposome-Based Nanovaccine against <i>Acinetobacter baumannii</i>-Associated Pneumonia in Immunocompetent and Immunocompromised Mice
by: Masood Alam Khan, et al.
Published: (2022-11-01) -
Safety and Therapeutic Efficacy of Thymoquinone-Loaded Liposomes against Drug-Sensitive and Drug-Resistant <i>Acinetobacter baumannii</i>
by: Khaled S. Allemailem, et al.
Published: (2021-05-01) -
Antimicrobial, Immunomodulatory and Anti-Inflammatory Potential of Liposomal Thymoquinone: Implications in the Treatment of Bacterial Pneumonia in Immunocompromised Mice
by: Khaled S. Allemailem, et al.
Published: (2021-11-01) -
The immune response in Acinetobacter baumannii pneumonia
by: Cristina Anca Tudor, et al.
Published: (2016-03-01) -
Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and <i>N</i>-Acetylcysteine against Tobramycin-Resistant <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, and <i>Acinetobacter baumannii</i>
by: Reem E. Alarfaj, et al.
Published: (2022-01-01)